My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Passage Bio, Inc. - Common Stock (NQ:PASG)

8.760 -0.560 (-6.01%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Passage Bio, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

November 14, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

Via Benzinga

Recap: Passage Bio Q3 Earnings ↗

November 13, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 03, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 03, 2023

Via Benzinga

Passage Bio And 2 Other Penny Stocks Insiders Are Aggressively Buying ↗

June 30, 2023

The Dow Jones closed higher by over 200 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Recap: Passage Bio Q1 Earnings ↗

May 11, 2023

Via Benzinga

Passage Bio's Earnings: A Preview ↗

March 03, 2023

Via Benzinga

Expert Ratings for Passage Bio ↗

December 15, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

June 15, 2023

On Thursday, 64 companies achieved new lows for the year.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

June 14, 2023

On Wednesday, 33 stocks hit new 52-week lows.

Via Benzinga

Passage Bio Stock Jumps After Gene Therapy Study In Lysosomal Storage Disorder ↗

December 14, 2022

Via Benzinga

Passage Bio: Q1 Earnings Insights ↗

May 16, 2022

Passage Bio (NASDAQ:PASG) reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For May 16, 2022 ↗

May 16, 2022

Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 03, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

March 27, 2023

On Monday, 89 stocks made new 52-week lows.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

December 15, 2022

It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 14, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022 ↗

November 08, 2022

Upgrades

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 16, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 12, 2022

Via Benzinga

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary ↗

August 11, 2022

Via Benzinga

Passage Bio Commences Initial-Stage Brain Disorder Study ↗

August 11, 2022

Passage Bio (NASDAQ: PASG) has dosed the first patient in the global Phase 1/2 upliFT-D clinical trial evaluating PBFT02 for the treatment of patients with frontotemporal dementia (FTD) with granulin...

Via Benzinga

Preview: Passage Bio's Earnings ↗

August 03, 2022

Passage Bio (NASDAQ:PASG) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that Passage Bio...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 08, 2022

Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 7.7% to $2.66 during Friday's after-market session. The market value of their outstanding shares is at $144.4 million.

Via Benzinga

This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday ↗

August 04, 2022

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume.

Via Benzinga

Why Poseida Therapeutics Is Trading Higher By Around 100%, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session ↗

August 03, 2022

Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday.

Via Benzinga

The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More ↗

May 16, 2022

Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from...

Via Benzinga

2 Stocks Under $3 Insiders Are Aggressively Buying ↗

May 06, 2022

US crude oil futures traded higher on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

April 20, 2022

On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 19, 2022

On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.